Mark Goldberg 🧠: Disappointing news for treatment of central retinal artery occlusion (CRAO, “stroke of the eye”). A new randomized trial shows no benefit of IV tenecteplase vs aspirin when given within 4.5 hours of onset. Fewer than 25% of patients in either group recovered vision. www.nejm.org/doi/10.1056/...

Disappointing news for treatment of central retinal artery occlusion (CRAO, “stroke of the eye”). A new randomized trial shows no benefit of IV tenecteplase vs aspirin when given within 4.5 hours of onset. Fewer than 25% of patients in either group recovered vision. www.nejm.org/doi/10.1056/...